Research News

11/8/18

Research led by Jonathan F. Lovell, PhD, associate professor of biomedical engineering, has provided a breakthrough in efforts to boost the efficacy of malarial transmission-blocking vaccines (TBV).

11/1/18

Research by Yun Wu, PhD, assistant professor of biomedical engineering, has led to a cancer-spotting tool that health care providers could eventually use in areas that lack hospitals, clinics and other treatment centers.

10/30/18

A study published in JAMA Pediatrics that rigorously assessed how the home environments of young children who are genetically at high risk for obesity can influence whether they become overweight or obese is being praised by University at Buffalo child obesity experts.

10/16/18

Researchers in the Department of Physiology and Biophysics have developed a promising therapy for Duchenne muscular dystrophy (DMD) that is moving closer to use in humans.

10/11/18

Research by John J. Leddy, MD, clinical assistant professor of orthopaedics, and Barry S. Willer, PhD, professor of psychiatry, did not find evidence of early-onset dementia (EOD) in a study of retired National Football League and National Hockey League players.

10/5/18

The Jacobs School of Medicine and Biomedical Sciences is benefiting from the expansion of clinical trials in Western New York.

10/5/18

A comprehensive effort to boost clinical research at the University at Buffalo is paying off and community members are reaping the benefits through increased participation in clinical trials.

9/19/18
UB researchers have received funding to apply the power of big data to enhance liver health in the Western New York region.
9/18/18

Researchers in the Department of Pathology and Anatomical Sciences have made surprising findings that challenge long-held scientific beliefs while studying the chewing behavior of carnivorans, the large mammalian order that includes dogs, cats and bears.

9/14/18

New information from Department of Biochemistry researchers on how manganese gets into the brain is helping to shed light on a neurological disorder usually associated with industrial overexposure to the metal.

9/14/18

UB’s Clinical and Translational Science Institute (CTSI) has announced $3 million in funding for the development and testing of methods to bring evidence-based findings into routine clinical practice.

9/13/18

A preclinical study conducted by researchers in the Department of Pharmacology and Toxicology has shown for the first time that a class of proteins are important in the neurobiology of relapse or drug-seeking behaviors.

8/29/18

Seventy-five student-scientists presented projects during the Eighth Annual Buffalo Summer Research Conference, an interdisciplinary forum marking the culmination of their summer research in Buffalo.

8/29/18

New research led by Panayotis (Peter) K. Thanos, PhD, a senior research scientist specializing in behavioral neuropharmacology at UB’s Research Institute on Addictions and the Department of Pharmacology and Toxicology, shows that exercise can help prevent relapse into cocaine addiction.

8/27/18

Research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified a new drug target for remyelination in multiple sclerosis (MS).